Health economic evaluations: How to find them

International Journal of Technology Assessment in Health Care

Volumn 22, Issue 4, 2006, Pages 512-517

  Alton, Viveka ^a   Eckerlund, Ingemar ^a   Norlund, Anders ^a  

^a Swedish Council on Technology Assessment in Health Care   (Sweden)

Author keywords

Bibliographic; Cost benefit analysis; Databases; Evaluation studies; Information storage and retrieval; Medical subject headings

Indexed keywords

BIBLIOGRAPHIC RETRIEVAL SYSTEMS; COST BENEFIT ANALYSIS; COST EFFECTIVENESS; DATA STORAGE EQUIPMENT; DATABASE SYSTEMS; DISEASES; ECONOMIC AND SOCIAL EFFECTS; PROJECT MANAGEMENT;

EVALUATION STUDIES; HEALTH ECONOMICS; MEDICAL SUBJECT HEADINGS; NATIONAL HEALTH SERVICE ECONOMIC EVALUATION DATABASE (NHS EED);

HEALTH CARE;

ARTICLE; BIBLIOGRAPHIC DATABASE; BIOMEDICAL TECHNOLOGY ASSESSMENT; COCHRANE LIBRARY; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC VALUE; ECONOMIC EVALUATION; GASTROINTESTINAL REFLUX; HEALTH ECONOMICS; INFORMATION RETRIEVAL; INFORMATION STORAGE; MEDICAL LITERATURE; MEDICAL RESEARCH; MEDLINE; PUBLICATION;

COST-BENEFIT ANALYSIS; DATABASES, BIBLIOGRAPHIC; DELIVERY OF HEALTH CARE; EVALUATION STUDIES; HUMANS; INFORMATION STORAGE AND RETRIEVAL; MEDICAL SUBJECT HEADINGS; PUBMED; REVIEW LITERATURE; TECHNOLOGY ASSESSMENT, BIOMEDICAL;

EID: 33750376999     PISSN: 02664623     EISSN: 14716348     Source Type: Journal    
DOI: 10.1017/S0266462306051452     Document Type: Article

References (17)

1. Bate CM, Riley SA, Chapman RW, Durnin AT, Taylor MD. Evaluation of omeprazole as a cost-effective diagnostic test for gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 1999;13:59-66.
2. Booth A, Fry-Smith A. Developing the research question. In: Etext on Health Technology Assessment (HTA) Information Resources. Available at: http://www.nlm.nih.gov/nichsr/ehta/chapter2.html.
3. Borzecki AM, Pedrosa MC, Prashker MJ. Should noncardiac chest pain be treated empirically? A cost-effectiveness analysis. Arch Intern Med. 2000;160:844-852.
4. Bytzer P, Hansen JM, Schaffalitzky de Muckadell OB. Empirical H2-blocker therapy or prompt endoscopy in management of dyspepsia. Lancet. 1994;343:811-816.
5. Canadian Agency for Drugs and Technologies in Health. Guidelines for the economic evaluation of health technologies: Canada. 3rd ed. Ottawa: Canadian Agency for Drugs and Technologies in Health; 2006.
6. Delaney BC, Wilson S, Roalfe A, et al. Cost effectiveness of initial endoscopy for dyspepsia in patients over age 50 years: A randomised controlled trial in primary care. Lancet. 2000;356:1965-1969.
7. Duggan AK. Modelling different approaches to the management of upper gastrointestinal disease. Pharmacoeconomics. 1999;14(Suppl 2):25-37.
8. Egger M, Juni P, Bartlett C, Holenstein F, Sterne J. How important are comprehensive literature searches and the assessment of trial quality in systematic reviews? Empirical study. Health Technol Assess. 2003;7:1-76.
9. Esfandyari T, Potter JW, Vaezi MF. Dysphagia: A cost analysis of the diagnostic approach. Am J Gastroenterol. 2002;97:2733-2737.
10. Fass R, Fennerty MB, Ofman JJ, et al. The clinical and economic value of a short course of omeprazole in patients with noncardiac chest pain. Gastroenterology. 1998;115:42-49.
11. Fass R, Ofman JJ, Gralnek IM, et al. Clinical and economic assessment of the omeprazole test in patients with symptoms suggestive of gastroesophageal reflux disease. Arch Intern Med. 1999;159:2161-2168.
12. Goulston KJ, Dent OF, Mant A, Logan J, Ngu M. Use of H2-receptor antagonists in patients with dyspepsia and heartburn: A cost comparison. Med J Aust. 1991;155:20-26.
13. Heudebert GR, Centor RM, Klapow JC, et al. What is heartburn worth? A cost-utility analysis of management strategies. J Gen Intern Med. 2000;15:175-182.
14. Laheij RJ, Severens JL, Van de Lisdonk EH, Verbeek AL, Jansen JB. Randomized controlled trial of omeprazole or endoscopy in patients with persistent dyspepsia: A cost-effectiveness analysis. Aliment Pharmacol Ther. 1998;12: 1249-1256.
15. Ofman JJ, Gralnek IM, Udani J, FennertyMB, Fass R. The cost-effectiveness of the omeprazole test in patients with noncardiac chest pain. Am J Med. 1999;107:219-227.
16. Ofman JJ, Dorn GH, Fennerty MB, Fass R. The clinical and economic impact of competing management strategies for gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2002;16:261-273.
17. Poynard T, Ottignon Y, Pauphilet C, Agostini H. Evaluation par un essai randomise de l'utilite de l'endoscopie apres le traitement d'une poussee d'oesophagite non-severe. Gastroenterol Clin Biol. 1997;21:497-502.